Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Deficit

v3.24.1
Consolidated Statements of Stockholders' Deficit - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Deferred Stock Based Compensation [Member]
Stock Subscription [Member]
Retained Earnings [Member]
Total
Balance, value at Dec. 31, 2021 $ 2 $ 165 $ 29,765,585 $ (900,742) $ (29,281,674) $ (416,664)
Balance, shares at Dec. 31, 2021 1,509 1,652,102          
Common stock issued for services $ 12 632,739 (150,589) 482,162
Balance, shares   118,750          
Conversion of debentures and accrued expenses $ 3 113,648 113,651
Balance, shares   27,624          
Incremental value from warrant modifications 41,225 (41,225)
Deemed dividend from Series A conversion price adjustment 342,497 (342,497)
Deemed dividend from Series B conversion price adjustment 30,938 (30,938)
Series A, preferred stock contractual dividends (27,620) (27,620)
Series B, preferred stock contractual dividends (151,309) (151,309)
Accretion of stock-based compensation to employees and directors 670,962 864,002 1,534,964
Balance, shares            
40:1 Reverse Split Fractional Shares Adjustment
Balance, shares   266          
Issuance of common stock for cash $ 31 1,402,469 $ 1,402,500
Balance, shares   311,666         626,917
Conversion of convertible debt to common stock $ 17 606,981 $ 606,998
Balance, shares   168,611          
Net loss (5,481,291) (5,481,291)
Balance, value at Dec. 31, 2022 $ 2 $ 228 33,428,115 (187,329) (35,177,625) (1,936,609)
Balance, shares at Dec. 31, 2022 1,509 2,279,019          
Common stock issued for services $ 14 700,325 150,590 850,929
Balance, shares   144,900          
Incremental value from warrant modifications 283,685 (282,309) 1,376
Deemed dividend from Series A conversion price adjustment 96,245 (96,245)
Deemed dividend from Series B conversion price adjustment 209,296 (209,296)
Series A, preferred stock contractual dividends (27,998) (27,998)
Series B, preferred stock contractual dividends (150,895) (150,895)
Accretion of stock-based compensation to employees and directors $ 27 1,711,320 (1,308,770) 402,577
Balance, shares   271,141          
Balance, shares            
Issuance of common stock for cash $ 30 1,164,216 $ 1,164,246
Balance, shares   296,304         1,330,363
Conversion of convertible debt to common stock $ 16 519,696 $ 519,712
Balance, shares   164,446          
Net loss (4,393,126) (4,393,126)
Sale of exclusivity option to Telix 2,000,000 2,000,000
Exercise of warrants for cash to common stock $ 37 1,094,964 1,095,001
Balance, shares   365,001          
Inducement for conversion of convertible debt 397,937 397,937
Conversion of Series A, preferred stock to common stock $ 8 239,992 240,000
Balance, shares   80,000          
Cashless exercise of warrants to common stock $ 1 (1)
Balance, shares   8,571          
Balance, value at Dec. 31, 2023 $ 2 $ 361 $ 41,666,897 $ (1,345,509) $ (40,158,601) $ 163,150
Balance, shares at Dec. 31, 2023 1,509 3,609,382